Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
753
-
Total 13F shares, excl. options
-
189M
-
Shares change
-
+20.6M
-
Total reported value, excl. options
-
$24.7B
-
Value change
-
+$2.71B
-
Put/Call ratio
-
1.16
-
Number of buys
-
428
-
Number of sells
-
-295
-
Price
-
$130.95
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q1 2021
927 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q1 2021.
Moderna, Inc. - COMMON STOCK (MRNA) has 753 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 189M shares
of 385M outstanding shares and own 49.07% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45.3M shares), BlackRock Inc. (20.8M shares), VANGUARD GROUP INC (18.9M shares), MORGAN STANLEY (8.22M shares), Theleme Partners LLP (6.3M shares), STATE STREET CORP (6.01M shares), FMR LLC (5.76M shares), GEODE CAPITAL MANAGEMENT, LLC (3.81M shares), BANQUE PICTET & CIE SA (3.04M shares), and Bellevue Group AG (2.81M shares).
This table shows the top 753 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.